Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Aoxing Buys Novel Menstrual Pain Drug

publication date: May 14, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Aoxing Pharmaceutical Company (中国奥星药业) has purchased the rights to a novel drug in Phase II trials that targets primary dysmenorrhea (PD), or menstrual pain. The drug, TJSL, is a capsule formulation of selected herbal medicines developed by Professor X. Tian, a well-known China gynecologist. Terms were not disclosed. With the initiative, China Aoxing will seek to extend its pain medication franchise into a new field. More details...

Stock Symbol: (OTCBB: CAXG)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors